Publication | Closed Access
Activity of cetuximab in patients with colorectal cancer refractory to both irinotecan and oxaliplatin
96
Citations
0
References
2004
Year
OncologyGastrointestinal OncologyMedicineColorectal CancerPathologyCancer TreatmentPharmacologyRadiation OncologyCancer ResearchColorectal Cancer Refractory
3510